Warda Faridi

404 total citations
13 papers, 257 citations indexed

About

Warda Faridi is a scholar working on Hematology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Warda Faridi has authored 13 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 3 papers in Molecular Biology and 2 papers in Organic Chemistry. Recurrent topics in Warda Faridi's work include Acute Myeloid Leukemia Research (2 papers), Renal cell carcinoma treatment (2 papers) and Viral-associated cancers and disorders (2 papers). Warda Faridi is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Renal cell carcinoma treatment (2 papers) and Viral-associated cancers and disorders (2 papers). Warda Faridi collaborates with scholars based in United States and Saudi Arabia. Warda Faridi's co-authors include Irbaz Bin Riaz, Mrinal M. Patnaik, Roshini S. Abraham, Saad Ullah Malik, Faiz Anwer, Muhammad Junaid Tariq, Seren Durer, Ali Younas Khan, Ceren Durer and Ali McBride and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Frontiers in Immunology.

In The Last Decade

Warda Faridi

13 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Warda Faridi United States	7	121	109	76	61	34	13	257
Cristina Castilla‐Llorente France	9	70 0.6×	77 0.7×	106 1.4×	65 1.1×	35 1.0×	40	260
Inna Timofeeva Italy	10	126 1.0×	81 0.7×	126 1.7×	65 1.1×	16 0.5×	17	273
László Gopcsa Hungary	13	92 0.8×	100 0.9×	132 1.7×	55 0.9×	53 1.6×	44	339
Sebastian Ginzel Germany	11	85 0.7×	186 1.7×	61 0.8×	50 0.8×	33 1.0×	16	331
Yusuke Meguri Japan	9	112 0.9×	186 1.7×	81 1.1×	29 0.5×	25 0.7×	32	285
K. Bienemann Germany	9	125 1.0×	265 2.4×	70 0.9×	52 0.9×	36 1.1×	12	367
Masanori Makita Japan	7	168 1.4×	139 1.3×	56 0.7×	90 1.5×	20 0.6×	21	270
Qingsong Yin China	8	156 1.3×	97 0.9×	56 0.7×	97 1.6×	108 3.2×	66	320
Teeraya Puavilai Thailand	8	142 1.2×	80 0.7×	85 1.1×	178 2.9×	63 1.9×	23	322
Hajime Yasuda Japan	11	111 0.9×	66 0.6×	93 1.2×	73 1.2×	115 3.4×	55	366

Countries citing papers authored by Warda Faridi

Since Specialization

Citations

This map shows the geographic impact of Warda Faridi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warda Faridi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warda Faridi more than expected).

Fields of papers citing papers by Warda Faridi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Warda Faridi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warda Faridi. The network helps show where Warda Faridi may publish in the future.

Co-authorship network of co-authors of Warda Faridi

This figure shows the co-authorship network connecting the top 25 collaborators of Warda Faridi. A scholar is included among the top collaborators of Warda Faridi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Warda Faridi. Warda Faridi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Faridi, Warda, et al.. (2024). Translating the ALS Genetic Revolution into Therapies: A Review. Current Treatment Options in Neurology. 26(3). 35–49. 2 indexed citations

Riaz, Irbaz Bin, Warda Faridi, Muhammad Husnain, et al.. (2019). Adjuvant Therapy in High-Risk Renal Cell Cancer: A Systematic Review and Meta-analysis. Mayo Clinic Proceedings. 94(8). 1524–1534. 6 indexed citations

Bilal, Jawad, Adam Berlinberg, Irbaz Bin Riaz, et al.. (2019). Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors. JAMA Network Open. 2(10). e1913102–e1913102. 32 indexed citations

Riaz, Irbaz Bin, Warda Faridi, Mrinal M. Patnaik, & Roshini S. Abraham. (2019). A Systematic Review on Predisposition to Lymphoid (B and T cell) Neoplasias in Patients With Primary Immunodeficiencies and Immune Dysregulatory Disorders (Inborn Errors of Immunity). Frontiers in Immunology. 10. 777–777. 50 indexed citations

Durer, Seren, Ceren Durer, Işın Y. Comba, et al.. (2019). Concomitant Use of Blinatumomab and Donor Lymphocyte Infusion for Mixed-Phenotype Acute Leukemia: A Case Report With Literature Review. Immunotherapy. 11(5). 373–378. 17 indexed citations

Malik, Saad Ullah, et al.. (2019). Does Obesity Influence the Efficacy of P2Y12 Inhibitors in Preventing Strokes? a Systematic Review and Meta-Analysis. Blood. 134(Supplement_1). 4950–4950. 1 indexed citations

Malik, Saad Ullah, Carol Howe, Tirdad T. Zangeneh, et al.. (2018). Prophylaxis for Hepatitis B Virus Reactivation after Allogeneic Stem Cell Transplantation in the Era of Drug Resistance and Newer Antivirals: A Systematic Review and Meta-Analysis. Biology of Blood and Marrow Transplantation. 24(7). 1483–1489. 7 indexed citations

Kumar, Abhijeet, Muhammad Usman, Saad Ullah Malik, et al.. (2018). Treating Diffuse Large B Cell Lymphoma in the Very Old or Frail Patients. Current Treatment Options in Oncology. 19(10). 50–50. 10 indexed citations

Khan, Ali Younas, Saad Ullah Malik, Warda Faridi, et al.. (2018). Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation. Biology of Blood and Marrow Transplantation. 25(1). 94–99. 127 indexed citations

10.

Durer, Ceren, Seren Durer, Muhammad Junaid Tariq, et al.. (2018). Efficacy and Toxicity Profile of Elotuzumab for Multiple Myeloma: A Systematic Review and Meta-Analysis. Blood. 132(Supplement 1). 5640–5640. 1 indexed citations

11.

Khan, Ali Younas, Seren Durer, Ceren Durer, et al.. (2018). A Systematic Review and Meta-Analysis: Efficacy and Toxicity Profile of Ixazomib for Treatment of Multiple Myeloma. Blood. 132(Supplement 1). 5639–5639. 2 indexed citations

12.

Sardar, Muhammad, et al.. (2018). Histone Deacetylase Inhibitors in Myelodysplastic Syndrome. Blood. 132(Supplement 1). 5528–5528. 1 indexed citations

13.

Riaz, Irbaz Bin, Saad Ullah Malik, Muhammad Husnain, et al.. (2018). A meta-analysis of randomized controlled trials for efficacy and safety of vascular endothelial growth factor tyrosine kinase inhibitors (VEGF-TKIs) adjuvant therapy in high-risk renal cell cancer (RCC).. Journal of Clinical Oncology. 36(15_suppl). 4567–4567. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact